The Enterprise Value as of November 2025 (TTM) for Y-mAbs Therapeutics, Inc. (YMAB) is 332.06M

According to Y-mAbs Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 332.06M. This represents a change of 21.85% compared to the average of 272.52M of the last 4 quarters.

Y-mAbs Therapeutics, Inc. (YMAB) Historical Enterprise Value (quarterly & annually)

How has YMAB Enterprise Value performed in the past?

The mean historical Enterprise Value of Y-mAbs Therapeutics, Inc. over the last ten years is 606.13M. The current 332.06M Enterprise Value has changed 5.38% with respect to the historical average. Over the past ten years (40 quarters), YMAB's Enterprise Value was at its highest in in the December 2020 quarter at 1.96B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Y-mAbs Therapeutics, Inc. (YMAB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Y-mAbs Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Y-mAbs Therapeutics, Inc. (YMAB) Average Enterprise Value

How has YMAB Enterprise Value performed in the past?

The current Enterprise Value of Y-mAbs Therapeutics, Inc. (YMAB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Y-mAbs Therapeutics, Inc. (YMAB) Enterprise Value vs. Peers

How is YMAB’s Enterprise Value compared to its peers?

Y-mAbs Therapeutics, Inc.’s Enterprise Value is less than G1 Therapeutics, Inc. (402.64M), less than Revance Therapeutics, Inc. (805.89M), less than Orchard Therapeutics plc (369.77M), less than Vigil Neuroscience, Inc. (346.93M), less than Checkpoint Therapeutics, Inc. (334.68M), greater than Climb Bio, Inc. (95.92M), greater than iTeos Therapeutics, Inc. (245.99M), greater than Sinovac Biotech Ltd. (-506209271.00), less than Big Cypress Acquisition Corp. (402.12M), greater than SomaLogic, Inc. (-23127083.00),

Build a custom stock screener for Y-mAbs Therapeutics, Inc. (YMAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Y-mAbs Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Y-mAbs Therapeutics, Inc. (YMAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Y-mAbs Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.